S1P RECEPTOR MODULATORS FOR THE THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS
CY1125622T1Undetermined Publication Date: 2026-04-17NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20221100678T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2006-06-27
- Filing Date
- 2022-10-13
- Publication Date
- 2026-04-17
- Estimated Expiration
- 2042-10-13
Abstract
The present invention relates to uses of an S1P receptor modulator such as 2-substituted derivatives of 2-amino-propane-1,3-diol or 2-1 amino-propanol, e.g. a compound comprising a group of formula (X) for the treatment or prevention of neoangiogenesis associated with a demyelinating disease.
Need to check novelty before this filing date? Find Prior Art